advertisement
 

  Back to News Legislative and Legal News

Current Legislative and Legal News

    1 November 2017

  1. Flurry Of Federal And State Probes Target Insulin Drugmakers And Pharma Middlemen.
  2. Several Probes Target Insulin Drug Pricing.

    25 October 2017

  3. JDRF advocates for all Canadians living with type 1 diabetes to be eligible for the Disability Tax Credit. See also Liberals accused of tax grab by clawing back disability credit for diabetics.

    18 October 2017

  4. AACE Celebrates Passage of the National Clinical Care Commission Act.
  5. Mum claims lives are in danger because schools are not fully aware of diabetes risks.

    10 October 2017

  6. Barring a schoolgirl from a school trip due to a type 1 diabetes appointment is discriminatory and unfair. See also Girl, 7, with diabetes is banned from school cinema trip because hospital appointment cost her 100% attendance record.

    27 September 2017

  7. Nevada's drug-pricing law faces new court hearing next month.

    30 August 2017

  8. New law aims to give peace of mind to parents of diabetic children.
  9. Did a School Illegally Expel Two Children for Type 1 Diabetes?

    26 July 2017

  10. Congress must extend critical federal funding for type 1 diabetes research.

    21 June 2017

  11. Nevada forces drugmakers to reveal insulin pricing, profits.

    14 June 2017

  12. Nevada bill would require insulin makers to post profits.

    7 June 2017

  13. New law lets schools help diabetic students.

    31 May 2017

  14. CVS, Abbott, Others Accused of Price Fixing Blood Sugar Tests.
  15. JDRF Campaign Targets US Healthcare Insurers in Type 1 Diabetes.

    17 May 2017

  16. White House says diabetics donít deserve health insurance. See also I Will Always Defend My Friends, Trumpís Budget Director Thinks People Choose to Have Diabetes, Donít Deserve Health Care, and Trump Official Says Diabetes a Preexisting Condition Not Worthy of Coverage.
  17. American Diabetes Association Extremely Disappointed and Saddened by Comments About People with Diabetes from White House Office of Management and Budget Director Mick Mulvaney.
  18. American Diabetes Association Responds to Comments by White House Office of Management and Budget Director Mick Mulvaney about People with Diabetes.

    10 May 2017

  19. Keeping my kids with diabetes alive costs thousands a year. Trumpcare terrifies me.

    3 May 2017

  20. New Virginia law relief for families involved with Type 1 diabetes advocacy.
  21. What the MacArthur Amendment Means for People with Type 1 Diabetes.
  22. A Secret Profit Formula Loved by Drug Middlemen Is at Risk.
  23. Calling PBMs (Pharmacy Benefit Managers) to the Carpet.

    26 April 2017

  24. Senator Bernie Sanders wants to know How Has the High Price of Insulin and Other Diabetes Medications Impacted You.
  25. Desperate Families Driven to Black Market Insulin.
  26. Mom charged with disruption says she just wanted insulin for son.
  27. Nevada Could Deal a Serious Blow to Insulin Manufacturers.

    19 April 2017

  28. Lilly Takes a Stab at Pricing Transparency, But Is It Enough of the Right Data?
  29. America Needs an Rx for Its Prescription Drug Prices is an editorial by Larry Smith and Larry Ellingson of the National Diabetes Volunteer Leadership Council. Both have served as the Chairman of the Board of the American Diabetes Association.

    12 April 2017

  30. The High Price of Insulin Is Literally Killing People.
  31. NHS risking people's health by rationing test strips, Diabetes UK says.

    29 March 2017

  32. Mitigating out-of-pocket costs for prescription drugs.
  33. Wyden Introduces Bill to Increase Transparency of PBMs.

    15 March 2017

  34. The T1D Exchange and Diabetes Patient Advocacy Coalition (DPAC) urge families to Act Now to Protect Affordable Healthcare for People with Type 1 Diabetes.
  35. Price of insulin has many with diabetes concerned about survival.

    8 March 2017

  36. Opening Up the Black Box on PBMs (Pharmacy Benefit Managers).

    1 March 2017

  37. The bare essentials: ensuring affordable access to insulin.

    22 February 2017

  38. Lawsuit accuses drug makers of conspiring to hike insulin prices.

    15 February 2017

  39. Judge Upends Effort To Limit Charity Funding For Kidney Patientsí Insurance.
  40. Three families pull diabetic children out of PWC Schools.

    8 February 2017

  41. Dear Congress: Don't take my 4-year-old son's life-saving health care away.

    1 February 2017

  42. Patients vs. Pharma: Hagens Berman files complaint against 'Big Three' insulin producers. You can read the 169-page suit. See also Is Pharma Breaking the Law?

    25 January 2017

  43. Support for Saskatchewan children with diabetes varies from school to school.

    18 January 2017

  44. JDRF Encouraged by Medicare Decision to Take First Step Toward Coverage of Continuous Glucose Monitors for People with Type 1 Diabetes. The full CMS ruling is available as a PDF.

    4 January 2017

  45. Rising insulin prices causing stress for Abilene diabetics.
  46. Soaring cost of life-saving drug becoming burden for diabetics.
  47. Rising cost of insulin concerns patients and doctors.

[ Current Legislative and Legal News | News from 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 ]



                 
  Back to News Return to Top

Last Updated: Wednesday November 15, 2017 19:50:17
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.

This site is published by T-1 Today, Inc. (d/b/a Children with Diabetes), a 501c3 not-for-profit organization, which is responsible for its contents. Our mission is to provide education and support to families living with type 1 diabetes.
By using this site, you agree to our Terms of Use, Legal Notice, and Privacy Policy.
© Children with Diabetes, Inc. 1995-2017. Comments and Feedback.